Amy Beumer
@amybeumer.bsky.social
MBC advocate and patient, microbiologist, educator, nature lover, gardener, reader, and feminist. She/her/hers.
Miss Gwen so much. Was just thinking of her yesterday and our chat.
Today would have been Gwen’s birthday. She was stolen from us by MBC.
One year ago, on a sunny afternoon before the last session of #SABCS23, I stood on this balcony chatting with patient and advocate Gwen Manchion, who was stolen by MBC in the interim. This is why we do what we do.
October 20, 2025 at 2:11 PM
Miss Gwen so much. Was just thinking of her yesterday and our chat.
Reposted by Amy Beumer
It's that time of the month again!
Do you love mail...fun mail?! Sign ups are open TODAY for our September Sunshine & Rainbows. 🌈
RSVP through the link in our bio 💌
#mbc #stage4needsmore #bcsm #busylivingwithmets #bccww
Do you love mail...fun mail?! Sign ups are open TODAY for our September Sunshine & Rainbows. 🌈
RSVP through the link in our bio 💌
#mbc #stage4needsmore #bcsm #busylivingwithmets #bccww
August 14, 2025 at 4:06 PM
It's that time of the month again!
Do you love mail...fun mail?! Sign ups are open TODAY for our September Sunshine & Rainbows. 🌈
RSVP through the link in our bio 💌
#mbc #stage4needsmore #bcsm #busylivingwithmets #bccww
Do you love mail...fun mail?! Sign ups are open TODAY for our September Sunshine & Rainbows. 🌈
RSVP through the link in our bio 💌
#mbc #stage4needsmore #bcsm #busylivingwithmets #bccww
Reposted by Amy Beumer
non-Governmental research funding is becoming more important every day. @metavivor.bsky.social received almost double the usual number of letters of intent last week. We need our supporters to be generous this year so we can fund promising research!
March 25, 2025 at 5:49 AM
non-Governmental research funding is becoming more important every day. @metavivor.bsky.social received almost double the usual number of letters of intent last week. We need our supporters to be generous this year so we can fund promising research!
Very concerned. And with the removal of information on health disparities and anything on health of the LGBTQ community.
As an editor and as an author this concerns me greatly. We should all be concerned.
February 3, 2025 at 7:18 PM
Very concerned. And with the removal of information on health disparities and anything on health of the LGBTQ community.
Reposted by Amy Beumer
REMINDER: ACE Meeting on cancer vaccines today 1pmPT / 4pmET. Join us to hear from advocate & ACE member Judy Fitzgerald as she shares her experience as an advocate on current vaccine trials. As always presentation will be short so bulk of the time can be spent on Q&A / discussion #OncoSky #Advocacy
January 14, 2025 at 4:31 PM
REMINDER: ACE Meeting on cancer vaccines today 1pmPT / 4pmET. Join us to hear from advocate & ACE member Judy Fitzgerald as she shares her experience as an advocate on current vaccine trials. As always presentation will be short so bulk of the time can be spent on Q&A / discussion #OncoSky #Advocacy
Tumor board Tuesday!! HR+ MBC! Looking forward to it @dr-rshatsky.bsky.social! #bcsm
January 9, 2025 at 5:31 PM
Tumor board Tuesday!! HR+ MBC! Looking forward to it @dr-rshatsky.bsky.social! #bcsm
Reposted by Amy Beumer
“Men with breast cancer are often left to fight the disease in silence. This silence has led to psychological and emotional distress in conjunction with illness-related stigmas.”
www.oncnursingnews.com/view/looking...
www.oncnursingnews.com/view/looking...
Looking More Closely at Breast Cancer in Male Patients
Although breast cancer has historically been associated with female patients, the rates of men with breast cancer have been increasing over the past decade.
www.oncnursingnews.com
December 28, 2024 at 4:19 AM
“Men with breast cancer are often left to fight the disease in silence. This silence has led to psychological and emotional distress in conjunction with illness-related stigmas.”
www.oncnursingnews.com/view/looking...
www.oncnursingnews.com/view/looking...
Reposted by Amy Beumer
It’s a privilege to be part of this meaningful work!
The ASCO CDK Dosing Study has the potential to reshape clinical practice for older adults w/ #metastaticbreastcancer. Thnx to PCORI for funding this impactful project.
@therightdose.bsky.social
@oncoalert.bsky.social
#bcsm
#DoseOptimization
#QoL
The ASCO CDK Dosing Study has the potential to reshape clinical practice for older adults w/ #metastaticbreastcancer. Thnx to PCORI for funding this impactful project.
@therightdose.bsky.social
@oncoalert.bsky.social
#bcsm
#DoseOptimization
#QoL
December 18, 2024 at 5:34 PM
It’s a privilege to be part of this meaningful work!
The ASCO CDK Dosing Study has the potential to reshape clinical practice for older adults w/ #metastaticbreastcancer. Thnx to PCORI for funding this impactful project.
@therightdose.bsky.social
@oncoalert.bsky.social
#bcsm
#DoseOptimization
#QoL
The ASCO CDK Dosing Study has the potential to reshape clinical practice for older adults w/ #metastaticbreastcancer. Thnx to PCORI for funding this impactful project.
@therightdose.bsky.social
@oncoalert.bsky.social
#bcsm
#DoseOptimization
#QoL
Home sweet home and an awesome sunset in flight.
December 14, 2024 at 11:28 PM
Home sweet home and an awesome sunset in flight.
Reposted by Amy Beumer
To build on the progress shared at #SABCS24 for triple-positive MBC ( #PATINA), when treatments stop working, is it the HER2 or HR component driving resistance? Need a biomarker! Patients want the most mileage from every treatment!
PS: Finally, +++ is being treated differently from HER2+/HR–.
PS: Finally, +++ is being treated differently from HER2+/HR–.
December 13, 2024 at 11:40 PM
Reposted by Amy Beumer
Was great to talk to @janicetnbcmets.bsky.social about this a couple days ago —> higher doses are not always better
✨ figuring out the best fit for our pts benefits those who experience a cancer diagnosis, oncologists, as well as pharma companies. Everyone wins with this knowledge!
#bcsm #SABCS24
✨ figuring out the best fit for our pts benefits those who experience a cancer diagnosis, oncologists, as well as pharma companies. Everyone wins with this knowledge!
#bcsm #SABCS24
December 14, 2024 at 1:14 AM
Was great to talk to @janicetnbcmets.bsky.social about this a couple days ago —> higher doses are not always better
✨ figuring out the best fit for our pts benefits those who experience a cancer diagnosis, oncologists, as well as pharma companies. Everyone wins with this knowledge!
#bcsm #SABCS24
✨ figuring out the best fit for our pts benefits those who experience a cancer diagnosis, oncologists, as well as pharma companies. Everyone wins with this knowledge!
#bcsm #SABCS24
Reposted by Amy Beumer
Hot of the press from @proteuspros - an infographic explaining the value of PROs!
Note - they need to start as parr of the clinical encounter to benefit patients and society.
tinyurl.com/3m594fhk
Note - they need to start as parr of the clinical encounter to benefit patients and society.
tinyurl.com/3m594fhk
December 13, 2024 at 6:24 PM
Hot of the press from @proteuspros - an infographic explaining the value of PROs!
Note - they need to start as parr of the clinical encounter to benefit patients and society.
tinyurl.com/3m594fhk
Note - they need to start as parr of the clinical encounter to benefit patients and society.
tinyurl.com/3m594fhk
Reposted by Amy Beumer
Spent 90 mins on the #SABCS24 stage, interjecting the advocacy perspective in "From the Trenches" yesterday. It was these voices, and so many others not pictured, that I channeled. Grateful to have them by my side literally & figuratively 💗
December 14, 2024 at 12:49 PM
Spent 90 mins on the #SABCS24 stage, interjecting the advocacy perspective in "From the Trenches" yesterday. It was these voices, and so many others not pictured, that I channeled. Grateful to have them by my side literally & figuratively 💗
There is no “good risk” only lower risk. There is no good DCIS. Need to talk about absolute risk as well. @coffeemommy.bsky.social #bcsm
December 14, 2024 at 12:44 AM
There is no “good risk” only lower risk. There is no good DCIS. Need to talk about absolute risk as well. @coffeemommy.bsky.social #bcsm
This! Also coffee…..
December 14, 2024 at 12:09 AM
This! Also coffee…..
Reposted by Amy Beumer
Here’s another impactful session about health disparities #systemic #structuralracism #global #healthequityforall #bcsm #oncoalert #SABCS24 @sabcs.bsky.social @oncoalert.bsky.social @swog.org @yabdoumd.bsky.social
December 13, 2024 at 5:38 PM
Here’s another impactful session about health disparities #systemic #structuralracism #global #healthequityforall #bcsm #oncoalert #SABCS24 @sabcs.bsky.social @oncoalert.bsky.social @swog.org @yabdoumd.bsky.social
@coffeemommy.bsky.social giving nuance to a conversation about patient treatment on Monday morning. Patients do not live in a utopia and we are not a monolith! #bcsm #sabcs24
December 14, 2024 at 12:05 AM
@coffeemommy.bsky.social giving nuance to a conversation about patient treatment on Monday morning. Patients do not live in a utopia and we are not a monolith! #bcsm #sabcs24
View from the trenches at #SABCS24 with the amazing @coffeemommy.bsky.social We need to “right size” treatment (NOT “deescalate”) with discussions on risk, benefit and impact of treatment. YES! #oncsky #bcsm
December 13, 2024 at 11:51 PM
View from the trenches at #SABCS24 with the amazing @coffeemommy.bsky.social We need to “right size” treatment (NOT “deescalate”) with discussions on risk, benefit and impact of treatment. YES! #oncsky #bcsm
This is great! Maybe add in ET alone in first line for select patients (SONIA). Great presentation by Dr. Danso. #bcsn #SABCS24
Fantastic ER+ #bcsm summary and algorithm by Dr. Danso at year in review.
First line CDK
2nd line profile driven
ADC/chemo once endo-R!
@sabcs.bsky.social
#SABCS24
@oncoalert.bsky.social
First line CDK
2nd line profile driven
ADC/chemo once endo-R!
@sabcs.bsky.social
#SABCS24
@oncoalert.bsky.social
December 13, 2024 at 11:22 PM
One year ago, on a sunny afternoon before the last session of #SABCS23, I stood on this balcony chatting with patient and advocate Gwen Manchion, who was stolen by MBC in the interim. This is why we do what we do.
December 13, 2024 at 11:12 PM
One year ago, on a sunny afternoon before the last session of #SABCS23, I stood on this balcony chatting with patient and advocate Gwen Manchion, who was stolen by MBC in the interim. This is why we do what we do.
Reposted by Amy Beumer
Congratulations to DR Steffi Oesterreichs @oesterreichs on her AACR Award. She has done sooooo much for people with ILC, not just through her brilliant research, but through her embrace of and collaboration with advocates. @metavivor is so proud to have funded her! #SABCS24
December 12, 2024 at 10:13 PM
Congratulations to DR Steffi Oesterreichs @oesterreichs on her AACR Award. She has done sooooo much for people with ILC, not just through her brilliant research, but through her embrace of and collaboration with advocates. @metavivor is so proud to have funded her! #SABCS24
Reposted by Amy Beumer
Dr @cittellylab.bsky.social’s
conclusions on brain mets in ER+ (MICE), and once again proud that @metavivor has funded her research! #SABCS24
conclusions on brain mets in ER+ (MICE), and once again proud that @metavivor has funded her research! #SABCS24
December 12, 2024 at 10:16 PM
Dr @cittellylab.bsky.social’s
conclusions on brain mets in ER+ (MICE), and once again proud that @metavivor has funded her research! #SABCS24
conclusions on brain mets in ER+ (MICE), and once again proud that @metavivor has funded her research! #SABCS24
Reposted by Amy Beumer
P-Verify is retrospx RWE look at OS in all 3 CDK4/6i w/Flatiron data, funded by Pfizer
▫️RWE is only way we’ll see this comparison -yet-
▫️RWE can have bias & limits -still-
▫️Reassuring to see NO DIFFERENCE in OS across 3 approved agents
▫️Needs longer F/U
#SABCS24 @oncoalert.bsky.social
▫️RWE is only way we’ll see this comparison -yet-
▫️RWE can have bias & limits -still-
▫️Reassuring to see NO DIFFERENCE in OS across 3 approved agents
▫️Needs longer F/U
#SABCS24 @oncoalert.bsky.social
December 12, 2024 at 1:52 PM
P-Verify is retrospx RWE look at OS in all 3 CDK4/6i w/Flatiron data, funded by Pfizer
▫️RWE is only way we’ll see this comparison -yet-
▫️RWE can have bias & limits -still-
▫️Reassuring to see NO DIFFERENCE in OS across 3 approved agents
▫️Needs longer F/U
#SABCS24 @oncoalert.bsky.social
▫️RWE is only way we’ll see this comparison -yet-
▫️RWE can have bias & limits -still-
▫️Reassuring to see NO DIFFERENCE in OS across 3 approved agents
▫️Needs longer F/U
#SABCS24 @oncoalert.bsky.social